Citation Impact
Citing Papers
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis
2007 Standout
A Pivotal Role for Heat Shock Protein 90 in Ewing Sarcoma Resistance to Anti-Insulin-like Growth Factor 1 Receptor Treatment: In vitro and In vivo Study
2008
Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
2015
Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients
2016
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Autophagy in cancers including brain tumors: role of MicroRNAs
2020
Astrocytes: biology and pathology
2009 Standout
Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy
2004 Standout
Hedgehog: functions and mechanisms
2008 Standout
IDH1andIDH2Mutations in Gliomas
2009 Standout
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
2012
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
2017 Standout
The future of high-grade glioma: Where we are and where are we going
2015
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
2009
Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma
2004
Glioblastoma and Other Malignant Gliomas
2013 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Autophagy in Brain Tumors: A New Target for Therapeutic Intervention
2011
The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation
2009
SCHEMA-Designed Variants of Human Arginase I and II Reveal Sequence Elements Important to Stability and Catalysis
2012 StandoutNobel
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors
2006
Immunohistochemical Staining for KIT (CD117) in Soft Tissue Sarcomas Is Very Limited in Distribution
2002
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Cancer genes and the pathways they control
2004 Standout
Cytokine patterns in patients with cancer: a systematic review
2013 Standout
Macrophage migration inhibitory factor: Roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma
2003
Malignant Gliomas in Adults
2008 Standout
Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib
2004
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
The IGF-1/PI3K/Akt Pathway Prevents Expression of Muscle Atrophy-Induced Ubiquitin Ligases by Inhibiting FOXO Transcription Factors
2004 Standout
Diagnosis of gastrointestinal stromal tumors: A consensus approach
2002 Standout
Primary brain tumours in adults
2012 Standout
Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age
2013
Therapeutic options for recurrent high-grade glioma in adult patients: Recent advances
2006
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
2010 Standout
KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic Correlation
2005
Alterations in the TGFβ signaling pathway in myogenic progenitors with age
2004
A Perivascular Niche for Brain Tumor Stem Cells
2007 Standout
Management of glioblastoma: State of the art and future directions
2020 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
2018 Standout
Efficacy and Tolerability of Temozolomide in an Alternating Weekly Regimen in Patients With Recurrent Glioma
2007
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth
2003
Therapeutic Application of Noncytotoxic Molecular Targeted Therapy in Gliomas: Growth Factor Receptors and Angiogenesis Inhibitors
2008
Diagnosis and Treatment of Recurrent High-Grade Astrocytoma
2006
Biology of Gastrointestinal Stromal Tumors
2004 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
2021 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments
2008
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
Therapeutic Advances in the Treatment of Glioblastoma: Rationale and Potential Role of Targeted Agents
2006
Second-Line Chemotherapy With Irinotecan Plus Carmustine in Glioblastoma Recurrent or Progressive After First-Line Temozolomide Chemotherapy: A Phase II Study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
2004
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
Lessons learned in the development of targeted therapy for malignant gliomas
2007
Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
2008
How effective is BCNU in recurrent glioblastoma in the modern era?
2004
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Regulation of insulin-like growth factor–dependent myoblast differentiation by Foxo forkhead transcription factors
2003
Works of L. Scopece being referenced
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
2007
Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
2004
The Metastatic Ability of Ewing's Sarcoma Cells Is Modulated by Stem Cell Factor and by Its Receptor c-kit
2000
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma
2009
First-Line Chemotherapy With Cisplatin Plus Fractionated Temozolomide in Recurrent Glioblastoma Multiforme: A Phase II Study of the Gruppo Italiano Cooperativo di Neuro-Oncologia
2004
Is protracted low-dose temozolomide feasible in glioma patients?
2006
Gefitinib (ZD1839) treatment for adult patients with progressive high-grade gliomas (HGG): An open label, single-arm, phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
2005
Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells
2001